COVID & Non-COVID, 3 Biotech Stocks To Watch
Against a backdrop in which investors remain keen on COVID-19 vaccine stocks such as Moderna and Novavax, and in which Biogen has just received the…
FDA
3 Biotech Stocks With Enormous Catalysts Early In 2021
When it comes to stocks with the potential to make big moves in the first quarter of 2021, the author of today’s article advises that…
These Biotechs Are Awaiting FDA Rulings In November
October has seen the FDA approve the first drug for COVID-19 (remdesivir), the first treatment for Ebola virus (Regeneron Pharmaceuticals’ Inmazeb), and the first drug…
PDUFA Dates: “Make-Or-Break Catalysts” For Biotech Stocks In October
Drugs for pain management, migraines, dry eye disease and Ebola are among those with PDUFA dates – deadlines by which the FDA must review new…
Biotech Catalysts For The Week Ahead
After a week in which they came under pressure, what does the week ahead have in store for biotech stocks? Today’s article outlines the key…
The FDA To Give This Biotech’s Potential Blockbuster Alzheimer’s Drug A Rapid Review
If the biotech highlighted in today’s article ends up getting its drug approved, it would be the first Alzheimer’s treatment that actually reduces the cognitive…
Attractive Prices And Plenty Of Upside Make These 2 “Cutting Edge” Cancer Stocks Potential Buys
In the cancer treatment space, today’s article highlights two small-cap biotech names to consider this month based on their attractive prices and potential to “take…
3 Top Stock Picks From The “Recession-Proof” Biotech Sector
It should come as no surprise that one of the top biotech stocks to consider right now, as identified by the author of today’s article,…